期刊文献+

叶下珠复方Ⅱ号对人肝癌HepG_2细胞增殖和凋亡作用 被引量:5

Inhibitory effect of compound phyllanthus urinaria Ⅱ (CPU Ⅱ) on proliferation of human hepatocellur carcinoma HepG_2 and induced apoptosis in vitro
原文传递
导出
摘要 目的探讨叶下珠复方II号(CPU II)对体外培养的人肝癌细胞HepG2增殖和凋亡的作用。方法采用四甲基偶氮唑盐比色法(MTT法),比较不同浓度的叶下珠复方在不同作用时间对体外培养的HepG2细胞增殖的影响;应用流式细胞术(FCM)结合Annexin V-FITC/PI荧光双染法观察CPU II诱导24h后人肝癌HepG2细胞的凋亡率。结果 MTT结果显示,人肝癌HepG2细胞经叶下珠复方II号处理一定时间后,增殖比率明显下降,2.60mg/ml以上的叶下珠II号对人肝癌HepG2细胞株的增殖有抑制作用(P<0.01;48h P<0.05),且呈一定的量效关系;FCM结果显示,随着叶下珠复方II号浓度的增加(2.6、26.0、130.0mg/ml),细胞的凋亡率也逐渐增加,差异有统计学意义(P<0.01)。结论叶下珠复方II号能够抑制人肝癌HepG2细胞生长和增殖,诱导人肝癌HepG2细胞凋亡,呈明显的量效关系。 Aim To investigate the effect of compound phyllanthus urinaria Ⅱ (CPU Ⅱ) on the proliferation of human hepatoma HepG2 cells and induced apoptosis in vitro. Methods The influence of different concentrations of CPU Ⅱ at different time on proliferation was compared by MTT colorimetric assay. Using tetrazolium salt assay (MTT) assay CPU Ⅱ,in human hepatoma HepG2 cell proliferation rate;Flow cytometry with FITC-Annexin V / PI fluorescence staining was observed 24h after CPU Ⅱ induced apoptosis rate of human hepatoma HepG2 ceils. Results MTF results showed that the proliferation of human hepatoma HepG2 ceils decreased significantly by CPU-Ⅱ dealing with a certain time,2.6mg/ml above CPU Ⅱ,in human hepatoma HepG2 cells inhibited the proliferation(P〈0.01 ;48h P〈0.05), and showed significant dose-effect relationship; aiong with the increase of CPU Ⅱ concentrations of CPU Ⅱ(2.6mg/ml, 26mg/ml, 130mg/ml ), cells apoptosis rate gradually increased, the difference was significant(P〈0.01 ). Conclusion CPU-Ⅱ can inhibit growth and proliferation and induce apoptosis in human hepatoma HepG2 cells, showed a significant dose-effect relationship.
出处 《中国热带医学》 CAS 2011年第7期810-812,共3页 China Tropical Medicine
关键词 叶下珠复方Ⅱ号 HepG2细胞 增殖 细胞凋亡 MTT ANNEXIN V—FITC/PI Compound Phyllanthus Urinaria Ⅱ(CPU Ⅱ) HepG2 cell proliferation apoptosis MTT Annexin V-FITC/PI
  • 相关文献

参考文献8

二级参考文献25

共引文献26

同被引文献36

  • 1Hong Lei Weng,Wei Min Cai,Rong Hua Liu Institute of Infectious Diseases, First Affiliated Hospital. Medical School. Zhejiang University, Hangzhou 310003, Zhejiang Province. China.Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis[J].World Journal of Gastroenterology,2001,7(1):42-48. 被引量:53
  • 2中华人民共和国卫生部药政局.新药(西药)临床前研究指导原则汇编[M].1993:89.
  • 3中华人民共和国卫生部药政局.中药新药临床前研究指导原则[M].199:88.
  • 4Han R. The Chemoprophylaxis and drug treatment of tumor [M]. Beijing:Peking Medical University and Peking Union Medical College Press, 1991.
  • 5Iliopoulos D,Jaeger S A,Hirsch H A, et al. STAT3 activation ofmiR-21 and miR-181b-l via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer [J]. Mol Cell, 2010, 39 (4) ; 493.
  • 6宇小荤,宇钢,宇常青,等.叶下钵复方II号对小鼠实验性肝损伤的保护作用[J].广州中医药大字字报,2007,24(5):392.
  • 7Kishimoto T. Interleukin-6 : from basic science to medicine-40 yearsin immunology [J]. Annu Rev Immunol,2005 , 23 ( 1 ) N : 1.
  • 8Denli A M,Tops B B,Plasterk R H, et al. Processing of primarymicroRNA by the Microprocessor complex [ J ]. Nature,2004,432: 231.
  • 9Gregory R I, Yan K P, Amuthan G, et al. The Microprocessorcomplex mediates the genesis of microRNA [ J ]. Nature,2004, 432: 235.
  • 10Karin M, Greten F R. NF-kappaB: linking inflammation and immunity to cancer development and progression [ J]. Nat Rev Immunol, 2005,5 (10) : 749 .

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部